NCT05316805View on ClinicalTrials.gov

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

RecruitingOBSERVATIONAL

Enrollment

100,000

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions

Atopic Dermatitis EczemaPrurigo Nodularis

Trial Locations (1)

Unknown

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Peking University First Hospital

OTHER